Clinical efficacy of Da Vinci robotic-assisted modified Soave operation for hirschsprung disease
Objective To evaluate the clinical efficacy of Da Vinci robotic-assisted modified Soave operation for hirschsprung disease.Methods From 2023 to 2024,14 children with hirschsprung disease underwent Da Vinci robotic-assisted modified Soave operation in the Affiliated Hospital of Zunyi Medical University were retrospec-tively analyzed.There were 5 females and 9 males,and the basic information,operative parameters,postoperative recovery,recent postoperative complications,and follow-up of the patients were recorded.Results All of them underwent Da Vinci robotic-assisted modified Soave operation,with a median age at surgery of 6 months,the weight was (10.7±5.9)kg,the operative time was (156.17±16.74)min,robot control console time was (60.01±8.18)min,the intraoperative blood loss was (7.71±2.01)ml,the postoperative gastric tube-re-tention time was (1.61±0.74)d,the postoperative oral feeding time was (1.78±0.69)d,the postopera-tive anal tube retention time was (5.35±1.73)d,and the postoperative hospitalization time was (7.57±1.28)d.All patients had no unplanned readmission for 30 days after surgery,and the follow-up time was (3.27±3.30)months.There was no serious complications(such as anastomotic strictures,cuff infection,anastomotic leakage)in the recent postoperative period,two cases had postoperative enterocolitis.Conclusion Da Vinci ro-botic-assisted modified Soave operation is a safe and feasible alternative for the treatment of hirschsprung disease,which is suitable to infant,even low weight infants,with accurate pelvic floor anatomy,thus it would reduce in-jury to anal sphincter,and eliminate the risk of secondary injury.
万方数据
维普
